Home › Companies › Biohaven Ltd. › 2025-2026

Biohaven Ltd. 2025-2026 Proxy Voting Records

Compiled from SEC Form N-PX filings and Biohaven Ltd.’s Form 8-K, filed May 4, 2026 (Item 5.07 on EDGAR). Page generated October 14, 2026.

5Ballot items
274Asset managers
1,283Fund votes
April 28, 2026Meeting date

Results at a glance

Meeting of April 28, 2026: 5 items on Biohaven Ltd.’s Form 8-K, filed May 4, 2026: 3 elected · 2 approved.

Material dissent

None.

Material dissent: a director nominee under 80% of the votes cast, say-on-pay under 70%, any other item the board put forward under 80%, or a shareholder proposal with more than 50%, on the company’s own Form 8-K tally. How this is decided

Proxy season: 2023-2024 2024-2025 2025-2026

Explore Biohaven Ltd. in the interactive database Compare manager voting policies

Official 2025-2026 meeting results reported by Biohaven Ltd.

These tallies are Biohaven Ltd.’s own, as disclosed to the U.S. Securities and Exchange Commission on Form 8-K, filed May 4, 2026 (Item 5.07, “Submission of Matters to a Vote of Security Holders”). They cover every share voted at the meeting, not just the funds that file Form N-PX.

Biohaven Ltd. — official shareholder meeting results, meeting held April 28, 2026
Ballot item	For	Against	Abstain	Withheld	Broker non-votes	Support (of votes cast)	Reported outcome	Voting standard
Elect Director: Michael T. Heffernan	76,133,746	15,092,665	1,984,918	--	--	83%	Elected	—
Elect Director: Irina Antonijevic, M.D., Ph.D.	76,612,017	14,616,115	1,983,197	--	--	84%	Elected	—
Elect Director: Robert J. Hugin	76,597,707	14,626,151	1,987,471	--	--	84%	Elected	—
2. Ratification of the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026	123,723,636	214,123	1,410,634	--	--	99.8%	Approved	—
3. Advisory vote on the compensation paid to the Company's named executive officers	87,521,620	4,202,883	1,486,826	--	--	95%	Approved	—

Source: Biohaven Ltd., Form 8-K, filed with the SEC on May 4, 2026 — read the filing on EDGAR.

How asset managers voted at the Biohaven Ltd. 2025-2026 meeting

Each item below shows how the 274 asset managers that disclosed a Biohaven Ltd. vote in their SEC Form N-PX filings actually voted. Share totals are the shares those managers' funds voted, summed across every fund they report.

1. Elect Director: Irina Antonijevic, M.D., Ph.D.

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%AGAINST

FOR: 76,612,017AGAINST: 14,616,115

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D., Ph.D.

Biohaven Ltd.’s own tally for this item (“Elect Director: Irina Antonijevic, M.D., Ph.D.”): 76,612,017 for, 14,616,115 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Broker Non-Votes: 32,137,064 All nominees were elected.”
Support: 84% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 26,362,767 for, 2,794,453 against, 12,535 abstained.

FOR

FOR: 26,362,767AGAINST: 2,794,453ABSTAIN: 12,535

Largest asset managers voting on “Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Irina Antonijevic, M.D.,” at Biohaven Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
JANUS INVESTMENT FUND	2,795,342	2,211,554	0	Mixed
BlackRock	4,782,388	0	0	For
Fidelity	4,217,284	0	0	For
State Street	3,582,113	0	0	For
Vanguard	3,469,201	80,231	3	For
T. Rowe Price	1,817,446	0	0	For
Capital Group	1,582,792	0	0	For
Simplify Exchange Traded Funds	1,038,365	0	0	For
Charles Schwab	861,954	0	0	For
TIAA	826,690	0	0	For
Equitable	228,357	0	0	For
JPMorgan	206,961	0	0	For
QUANTITATIVE MASTER SERIES LLC	153,564	0	0	For
EA Series Trust	148,520	0	0	For
Lincoln Financial	99,607	19,130	0	Mixed
Brighthouse	62,835	38,653	12,532	Mixed
ProShares	0	94,572	0	Against
Goldman Sachs	73,266	0	0	For
Direxion Shares ETF Trust	0	62,516	0	Against
John Hancock	31,509	27,892	0	Mixed
AIG/SunAmerica	0	56,465	0	Against
Roundhill ETF Trust	0	53,413	0	Against
Northern Trust	49,313	0	0	For
Global X	43,164	0	0	For
Northern Lights Fund Trust IV	42,502	0	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

2. Elect Director: Michael T. Heffernan

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

83% Majority: yes · of votes cast

FOR 83%AGAINST

FOR: 76,133,746AGAINST: 15,092,665

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan

Biohaven Ltd.’s own tally for this item (“Elect Director: Michael T. Heffernan”): 76,133,746 for, 15,092,665 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

Reported outcome: Elected, in the filing’s own words: “Broker Non-Votes: 32,137,064 All nominees were elected.”
Support: 83% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 26,344,014 for, 2,813,206 against, 12,535 abstained.

FOR

FOR: 26,344,014AGAINST: 2,813,206ABSTAIN: 12,535

Largest asset managers voting on “Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Michael T. Heffernan” at Biohaven Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
JANUS INVESTMENT FUND	2,795,342	2,211,554	0	Mixed
BlackRock	4,782,388	0	0	For
Fidelity	4,217,284	0	0	For
State Street	3,582,113	0	0	For
Vanguard	3,473,530	75,902	3	For
T. Rowe Price	1,817,446	0	0	For
Capital Group	1,582,792	0	0	For
Simplify Exchange Traded Funds	1,038,365	0	0	For
Charles Schwab	861,954	0	0	For
TIAA	826,690	0	0	For
Equitable	228,357	0	0	For
JPMorgan	206,961	0	0	For
QUANTITATIVE MASTER SERIES LLC	153,564	0	0	For
EA Series Trust	148,520	0	0	For
Lincoln Financial	99,607	19,130	0	Mixed
Brighthouse	62,835	38,653	12,532	Mixed
ProShares	0	94,572	0	Against
Goldman Sachs	73,266	0	0	For
Direxion Shares ETF Trust	0	62,516	0	Against
John Hancock	31,509	27,892	0	Mixed
AIG/SunAmerica	0	56,465	0	Against
Roundhill ETF Trust	0	53,413	0	Against
Northern Trust	49,313	0	0	For
Global X	43,164	0	0	For
Northern Lights Fund Trust IV	42,502	0	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

3. Elect Director: Robert J. Hugin

Official resultDIRECTOR ELECTIONSReported outcome: Elected

Combines 3 wordings of this item as funds reported it.

84% Majority: yes · of votes cast

FOR 84%AGAINST

FOR: 76,597,707AGAINST: 14,626,151

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin

Biohaven Ltd.’s own tally for this item (“Elect Director: Robert J. Hugin”): 76,597,707 for, 14,626,151 against, per its Form 8-K filed May 4, 2026 (Item 5.07). FOR was more than half of the votes cast. Whether the item passed is for the filing to say; its statement has not been read for this item.

The 56 asset managers below reported 26,367,096 for, 2,790,123 against, 12,535 abstained.

FOR

FOR: 26,367,096AGAINST: 2,790,123ABSTAIN: 12,535

Largest asset managers voting on “Election of Directors for a term expiring at the 2029 Annual Meeting of shareholders: Robert J. Hugin” at Biohaven Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
JANUS INVESTMENT FUND	2,795,342	2,211,554	0	Mixed
BlackRock	4,782,388	0	0	For
Fidelity	4,217,284	0	0	For
State Street	3,582,113	0	0	For
Vanguard	3,473,530	75,901	3	For
T. Rowe Price	1,817,446	0	0	For
Capital Group	1,582,792	0	0	For
Simplify Exchange Traded Funds	1,038,365	0	0	For
Charles Schwab	861,954	0	0	For
TIAA	826,690	0	0	For
Equitable	228,357	0	0	For
JPMorgan	206,961	0	0	For
QUANTITATIVE MASTER SERIES LLC	153,564	0	0	For
EA Series Trust	148,520	0	0	For
Lincoln Financial	99,607	19,130	0	Mixed
Brighthouse	62,835	38,653	12,532	Mixed
ProShares	0	94,572	0	Against
Goldman Sachs	73,266	0	0	For
Direxion Shares ETF Trust	0	62,516	0	Against
John Hancock	31,509	27,892	0	Mixed
AIG/SunAmerica	0	56,465	0	Against
Roundhill ETF Trust	0	53,413	0	Against
Northern Trust	49,313	0	0	For
Global X	43,164	0	0	For
Northern Lights Fund Trust IV	42,502	0	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

4. 3. Advisory vote on the compensation paid to the Company's named executive officers

Official result Fund totals may overlapSECTION 14A SAY-ON-PAY VOTESReported outcome: Approved

Combines 11 wordings of this item as funds reported it.

95% Approved · of votes cast

FOR 95%

FOR: 87,521,620AGAINST: 4,202,883

Details: description as filed, official tally, votes by 274 asset managers

Description as filed by funds: A non-binding advisory vote on the compensation of the Company's named executive officers.

Biohaven Ltd.’s own tally for this item (“3. Advisory vote on the compensation paid to the Company's named executive officers”): 87,521,620 for, 4,202,883 against — passed, per its Form 8-K filed May 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Proposal 3: Advisory vote on the compensation paid to the Company's named executive officers.”
Support: 95% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

Fund voting reports and institutional-manager reports both cover this item. An institutional manager can report shares that a fund it advises also reports, so the two are shown separately below and never added together, and their sum is not shown (fund and manager reports combined may count the same shares twice).

Fund voting reports: 55 asset managers voting on “A non-binding advisory vote on the compensation of the Company's named executive officers.” at Biohaven Ltd., 2025-2026
Asset manager	For	Against	Abstain	Vote
JANUS INVESTMENT FUND	5,006,896	0	0	For
BlackRock	4,782,388	0	0	For
Fidelity	4,217,284	0	0	For
State Street	3,582,113	0	0	For
Vanguard	3,537,055	12,377	3	For
T. Rowe Price	1,817,446	0	0	For
Capital Group	0	1,582,792	0	Against
Simplify Exchange Traded Funds	1,038,365	0	0	For
Charles Schwab	861,954	0	0	For
TIAA	826,690	0	0	For
Equitable	228,357	0	0	For
JPMorgan	206,961	0	0	For
QUANTITATIVE MASTER SERIES LLC	153,564	0	0	For
EA Series Trust	148,520	0	0	For
Lincoln Financial	118,737	0	0	For
Brighthouse	101,488	0	12,532	Mixed
ProShares	94,572	0	0	For
Goldman Sachs	73,266	0	0	For
Direxion Shares ETF Trust	62,516	0	0	For
John Hancock	59,401	0	0	For
AIG/SunAmerica	56,465	0	0	For
Roundhill ETF Trust	53,413	0	0	For
Northern Trust	49,313	0	0	For
Global X	43,164	0	0	For
Northern Lights Fund Trust IV	42,502	0	0	For

Fund voting reports, all 55 managers: 27,541,161 for, 1,615,939 against, 12,535 abstained. Showing the 25 largest; see all in the interactive database.

Institutional-manager reports: 233 asset managers voting on “A non-binding advisory vote on the compensation of the Company's named executive officers.” at Biohaven Ltd., 2025-2026
Asset manager	For	Against	Withheld	Vote
Janus Henderson	33,681,007	40,486	0	For
1919 Investment Counsel, LLC	9,793,588	0	0	For
MONTANOVA CAPITAL, LLC	8,597,649	0	0	For
BlackRock	4,943,225	20,341	0	For
T. Rowe Price	2,541,831	0	0	For
GEODE CAPITAL MANAGEMENT, LLC	2,465,861	0	0	For
Fidelity	2,299,412	0	0	For
State Street	1,816,756	22,899	0	For
DE Shaw	1,605,153	0	0	For
ADAGE CAPITAL PARTNERS GP, L.L.C.	1,500,000	0	0	For
AQR	1,465,324	0	0	For
Cormorant Asset Management, LP	1,440,995	0	0	For
Capital Research Global Investors	0	1,332,792	0	Against
Two Sigma	1,067,279	0	0	For
Vanguard	870,173	0	0	For
Charles Schwab	862,352	0	0	For
DAFNA Capital Management LLC	845,735	0	0	For
Nuveen	840,669	0	0	For
5AM Venture Management, LLC	738,972	0	0	For
Kynam Capital Management, LP	0	0	702,884	Withhold
Northern Trust	679,837	14,372	0	For
Aberdeen	0	693,452	0	Against
Integral Health Asset Management, LLC	664,094	0	0	For
BALYASNY ASSET MANAGEMENT L.P.	523,095	0	0	For
Fiera Capital Corp	418,470	19,214	0	For

Institutional-manager reports, all 233 managers: 83,077,262 for, 3,405,867 against, 702,884 withheld, 207,373 abstained, 852 not voted. Showing the 25 largest; see all in the interactive database.

5. 2. Ratification of the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31…

Official resultAUDIT-RELATEDReported outcome: Approved

Combines 2 wordings of this item as funds reported it.

99.8% Approved · of votes cast

FOR 99.8%

FOR: 123,723,636AGAINST: 214,123

Details: description as filed, official tally, votes by 56 asset managers

Description as filed by funds: RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR FISCAL YEAR 2026.

Biohaven Ltd.’s own tally for this item (“2. Ratification of the appointment of Ernst & Young LLP as independent auditors for the fiscal year ending December 31, 2026”): 123,723,636 for, 214,123 against — passed, per its Form 8-K filed May 4, 2026 (Item 5.07).

Reported outcome: Approved, in the filing’s own words: “Broker Non-Votes: 0 Proposal No. 2 was approved.”
Support: 99.8% of votes cast — FOR ÷ (FOR + AGAINST); abstentions and broker non-votes are excluded.

The 56 asset managers below reported 29,157,220 for, 12,535 abstained.

FOR

FOR: 29,157,220ABSTAIN: 12,535

Largest asset managers voting on “RATIFICATION OF APPOINTMENT OF ERNST & YOUNG LLP AS INDEPENDENT AUDITORS FOR FISCAL YEAR 2026.” at Biohaven Ltd., 2025-2026
Asset manager	For	Abstain	Vote
JANUS INVESTMENT FUND	5,006,896	0	For
BlackRock	4,782,388	0	For
Fidelity	4,217,284	0	For
State Street	3,582,113	0	For
Vanguard	3,549,432	3	For
T. Rowe Price	1,817,446	0	For
Capital Group	1,582,792	0	For
Simplify Exchange Traded Funds	1,038,365	0	For
Charles Schwab	861,954	0	For
TIAA	826,690	0	For
Equitable	228,357	0	For
JPMorgan	206,961	0	For
QUANTITATIVE MASTER SERIES LLC	153,564	0	For
EA Series Trust	148,520	0	For
Lincoln Financial	118,737	0	For
Brighthouse	101,488	12,532	Mixed
ProShares	94,572	0	For
Goldman Sachs	73,266	0	For
Direxion Shares ETF Trust	62,516	0	For
John Hancock	59,401	0	For
AIG/SunAmerica	56,465	0	For
Roundhill ETF Trust	53,413	0	For
Northern Trust	49,313	0	For
Global X	43,164	0	For
Northern Lights Fund Trust IV	42,502	0	For

Showing the 25 largest of 56 asset managers. See all 56 in the interactive database.

Largest Biohaven Ltd. shareholders voting in 2025-2026

Ranked separately for each type of Form N-PX report. An institutional manager can report shares that a fund it advises also reports, so the two tables can list the same shares and are never added together. Each is ranked by the shares voted on the item that the most managers of that type reported, shown as a share of the 150,506,490 shares outstanding at the time of that meeting.

Fund voting reports: top Biohaven Ltd. shareholders by shares voted on “A non-binding advisory vote on the compensation of the Company's named executive officers.”, 2025-2026
#	Asset manager	% of shares outstanding
1	JANUS INVESTMENT FUND	3.33%
2	BlackRock	3.18%
3	Fidelity	2.80%
4	State Street	2.38%
5	Vanguard	2.36%
6	T. Rowe Price	1.21%
7	Capital Group	1.05%
8	Simplify Exchange Traded Funds	0.69%
9	Charles Schwab	0.57%
10	TIAA	0.55%

Institutional-manager reports: top Biohaven Ltd. shareholders by shares voted on “A non-binding advisory vote on the compensation of the Company's named executive officers.”, 2025-2026
#	Asset manager	% of shares outstanding
1	Janus Henderson	22.41%
2	1919 Investment Counsel, LLC	6.51%
3	MONTANOVA CAPITAL, LLC	5.71%
4	BlackRock	3.30%
5	T. Rowe Price	1.69%
6	GEODE CAPITAL MANAGEMENT, LLC	1.64%
7	Fidelity	1.53%
8	State Street	1.22%
9	DE Shaw	1.07%
10	ADAGE CAPITAL PARTNERS GP, L.L.C.	1.00%

Reported Biohaven Ltd. holdings and ownership

As disclosed to the SEC in Form 13F (quarter-end holdings of 30 large managers), Schedules 13D and 13G (beneficial ownership above 5%) and the company’s own proxy statement (DEF 14A). Each row names its form.

Biohaven Ltd. holdings and ownership disclosed for the 2025-2026 proxy season
Holder	% outstanding	Disclosure
BlackRock	7.46%	13F
Suvretta Capital Management, LLC	6.83%	DEF14A
John Childs	6.69%	DEF14A
JANUS HENDERSON GROUP Ltd.	5.70%	13G
Woodline Partners LP	5.09%	13G
State Street	4.40%	13F
Vlad Coric, M.D.	3.64%	DEF14A
Vanguard Group	2.92%	13F
D.E. Shaw	1.89%	13F
Goldman Sachs	1.67%	13F

Percentages above are of 150,506,490 shares outstanding, as reported by Biohaven Ltd. on its Form 10-Q dated March 31, 2026 (see the filing on EDGAR). This is the count contemporaneous with the 2025-2026 meeting, not today’s. Each holding is as of its own filing, which may be dated before or after the meeting.

About this page

Every figure above is derived from filings made with the US Securities and Exchange Commission: Form N-PX, in which registered funds disclose how they voted every proxy and institutional managers disclose their votes on executive pay (say-on-pay, say-on-frequency and golden parachutes), and Form 8-K Item 5.07, in which the company reports its own meeting results. Shares outstanding are taken from Biohaven Ltd.’s 10-Q dated March 31, 2026. This page is a static snapshot rebuilt weekly on October 14, 2026; a live search always shows the current data.

At Biohaven Ltd.'s shareholder meeting held April 28, 2026, in the 2025-2026 proxy season, 274 asset managers reported how they voted on 5 ballot items in their SEC Form N-PX filings, covering 1,283 separate fund positions. On the most widely held item on that ballot — A non-binding advisory vote on the compensation of the Company's named executive officers. — Biohaven Ltd.'s filing reports the proposal as approved, with 95% support of the votes cast (FOR divided by FOR plus AGAINST, the conventional basis for proxy support; abstentions, broker non-votes and unvoted shares are excluded because none of them took a side). Source: Biohaven Ltd.'s Form 8-K, Item 5.07, filed with the U.S. Securities and Exchange Commission on May 4, 2026.

Biohaven Ltd. proxy season coverage: 2023-2024 · 2024-2025 · 2025-2026 (this page).

Download data (CSV): ballot items · votes by manager · column guide.